-
Pathological Assessment of Ovarian Cancer
Ovarian neoplasms are notoriously heterogeneous-the World Health Organization cl
-
Estrogen-Responsive Ovarian Cancer Xenografts
The use of human tumor xenografts grown in immunodeficient animals as a model fo
-
Reverse Phase Protein Microarrays for Monitoring Biological Responses
Cancer has a genomic and proteomic basis. Genomic information provides informati
-
Multifactorial Etiology of Gastric Cancer
The prevalence of gastric cancer is associated with several factors including ge
-
The Principles of MiRNA-Masking Antisense Oligonucleotides Technology
MiRNA-masking antisense oligonucleotides technology (miR-mask) is an anti-microR
-
Flow Cytometric Detection of Activated Caspase-3
Apoptosis (programmed cell death) is an active process that plays a critical rol
-
MUC1 Expression in Lung Cancer
Abnormalities in mucin-type glycoprotein expression have been documented in a va
-
Detection and Genotyping Analysis of Human Papillomavirus Isolates from Liquid-Based Cervical Cytolo
The detection of oncogenic subtypes of human papillomavirus (HPV) from exfoliate
-
Colloidal Gold: A Novel Nanoparticle for Targeted Cancer Therapeutics
Since their initial description in 1857, gold nanoparticles have been used exten
-
Bispecific Diabodies for Cancer Therapy
Natural killer (NK) cells represent a potent subset of lymphocytes for targeting
-
An Overview: From Discovery of Candidate Mutations to Disease Modeling and Transformation Mechanisms
Acute leukemia is an aggressive form of hematological malignancy, which is chara
-
Surgical Treatment of Lung Cancer: Past And Present
From the fortuitous beginning of surgery of the chest in the 15th century to the
-
A Method for Conducting Highly Sensitive MicroRNA In Situ Hybridization and Immunohistochemical Anal
Profiling experiments in whole tissue biopsies have linked altered expression of
-
Cloning of Immunoglobulin Chromosomal Translocations by Long-Distance Inverse Polymerase Chain React
Many subtypes of B-cell malignancy are characterized by chromosomal translocatio
-
Clinical Application of Tissue and Serum Markers in Breast Cancer
How different the practice of oncology would become if physicians could predict
